- Home
- VSTM vs KREF Comparison
VSTM vs KREF Comparison
Compare VSTM & KREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- KREF
- Stock Information
- Founded
- VSTM 2010
- KREF 2014
- Country
- VSTM United States
- KREF United States
- Employees
- VSTM N/A
- KREF N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- KREF Real Estate Investment Trusts
- Sector
- VSTM Health Care
- KREF Real Estate
- Exchange
- VSTM Nasdaq
- KREF Nasdaq
- Market Cap
- VSTM 598.2M
- KREF 623.9M
- IPO Year
- VSTM 2012
- KREF 2017
- Fundamental
- Price
- VSTM $8.94
- KREF $8.61
- Analyst Decision
- VSTM Strong Buy
- KREF Buy
- Analyst Count
- VSTM 9
- KREF 6
- Target Price
- VSTM $13.38
- KREF $12.04
- AVG Volume (30 Days)
- VSTM 1.7M
- KREF 879.5K
- Earning Date
- VSTM 11-05-2025
- KREF 10-21-2025
- Dividend Yield
- VSTM N/A
- KREF 11.63%
- EPS Growth
- VSTM N/A
- KREF N/A
- EPS
- VSTM N/A
- KREF N/A
- Revenue
- VSTM $2,137,000.00
- KREF $40,393,000.00
- Revenue This Year
- VSTM $88.50
- KREF $23.74
- Revenue Next Year
- VSTM $398.66
- KREF N/A
- P/E Ratio
- VSTM N/A
- KREF N/A
- Revenue Growth
- VSTM N/A
- KREF N/A
- 52 Week Low
- VSTM $2.54
- KREF $8.28
- 52 Week High
- VSTM $11.25
- KREF $12.33
- Technical
- Relative Strength Index (RSI)
- VSTM 53.26
- KREF 31.65
- Support Level
- VSTM $8.49
- KREF $8.60
- Resistance Level
- VSTM $9.14
- KREF $9.13
- Average True Range (ATR)
- VSTM 0.43
- KREF 0.18
- MACD
- VSTM -0.10
- KREF -0.09
- Stochastic Oscillator
- VSTM 54.31
- KREF 7.49
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About KREF KKR Real Estate Finance Trust Inc.
KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.